These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 12866294

  • 1. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 2. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov 13; 145(46):47. PubMed ID: 14699834
    [No Abstract] [Full Text] [Related]

  • 3. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct 31; 144(44):55. PubMed ID: 12494604
    [No Abstract] [Full Text] [Related]

  • 4. Combined salmeterol and fluticasone for COPD.
    Vassiliou V.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Lung; 2006 May 10; 184(4):217-22. PubMed ID: 17006748
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Salmeterol/fluticasone combination in the treatment of COPD.
    Chung KF.
    Int J Chron Obstruct Pulmon Dis; 2006 May 10; 1(3):235-42. PubMed ID: 18046860
    [Abstract] [Full Text] [Related]

  • 9. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.
    Ann Intern Med; 2007 Apr 17; 146(8):I12. PubMed ID: 17310044
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
    Schultze-Werninghaus G.
    Med Klin (Munich); 2002 Dec 15; 97 Suppl 2():1. PubMed ID: 12593173
    [No Abstract] [Full Text] [Related]

  • 12. Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal?
    Brown SM.
    Ann Intern Med; 2007 Dec 18; 147(12):882; author reply 882-3. PubMed ID: 18087061
    [No Abstract] [Full Text] [Related]

  • 13. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
    Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Rousseau R, ABC (Advair, Biomarkers in COPD) Investigators.
    BMC Pulm Med; 2006 Feb 06; 6():3. PubMed ID: 16460562
    [Abstract] [Full Text] [Related]

  • 14. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
    Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK, SCO30005 Study Group.
    Am J Respir Crit Care Med; 2006 Apr 01; 173(7):736-43. PubMed ID: 16424444
    [Abstract] [Full Text] [Related]

  • 15. Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate.
    Easton PA, Hawes HG, Doig CJ, Johnson MW, Yokoba M, Wilde ER.
    Chest; 2010 Mar 01; 137(3):558-65. PubMed ID: 19820074
    [Abstract] [Full Text] [Related]

  • 16. [Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study].
    Seeger W, Schulz R.
    Internist (Berl); 2004 Jun 01; 45(6):727-8. PubMed ID: 15138641
    [No Abstract] [Full Text] [Related]

  • 17. Predictive factors for evaluation of response to fluticasone propionate/salmeterol combination in severe COPD.
    Tonnel AB, Tillie-Leblond I, Attali V, Bavelele Z, Lagrange O.
    Respir Med; 2011 Feb 01; 105(2):250-8. PubMed ID: 20702076
    [Abstract] [Full Text] [Related]

  • 18. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.
    Terzano C, Petroianni A, Ricci A, Allegra L.
    Eur Rev Med Pharmacol Sci; 2005 Feb 22; 9(4):209-15. PubMed ID: 16128040
    [Abstract] [Full Text] [Related]

  • 20. Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.
    Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P, TRISTAN Study Group.
    Respir Med; 2004 Nov 22; 98(11):1045-50. PubMed ID: 15526804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.